Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of spironolactone and erythromycin solution in treatment of acne
IRCT20181005041243N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of spironolactone and erythromycin in acne vulgaris, sponsored by Tehran University of Medical Sciences. Started Nov 2022; status: completed.
02
Drugs
spironolactoneerythromycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20181005041243N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181005041243N1.